Filter
1302
Text search:
HIV
diagnostics
Featured
149
362
Language
Document type
763
208
169
61
43
21
17
8
7
2
2
1
Countries / Regions
54
45
43
38
31
29
27
26
25
25
22
21
21
21
19
19
17
17
15
13
13
13
12
11
11
11
10
10
10
7
7
7
6
6
6
5
5
5
5
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
448
149
50
38
25
20
7
1
Toolboxes
291
245
76
69
26
25
21
18
15
15
15
14
13
13
13
11
8
6
5
4
3
1
This document describes the key areas that national governments should consider for the introduction and scale-up of point-of-care (POC) diagnostics within national programmes, as new innovative POC technologies are being introduced into the market.
...
Evaluation report
January 2014
Downloaded from https://aidsinfo.nih.gov/guidelines on 11/27/2019
Visit the AIDSinfo website to access the most up-to-date guideline.
Register for e-mail notification of guideline updates at https://aidsinfo.nih.gov/e-news.
Evaluation report
April 2013
Evaluation report
This report is part of the overall Ukrainian National AIDS programme evaluation conducted
in September 2012
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
Frontiers in Pediatrics | www.frontiersin.org
1 April 2019 | Volume 7 | Article 159
This policy brief describes key HIV viral load thresholds and the available viral load testing approaches for monitoring how well antiretroviral therapy is working for people living with HIV. It pro
...
PQDx 0018-010-00 WHO
PQDx PR
July/2016, version 3.0
Module 10
Testing providers
July 2017
Module 10: Testing providers. This module is for people who provide testing services at PrEP sites and laboratories. It offers guidance in selecting testing services, including screening of individuals before PrEP is initiated and monitoring while they ar
...
Key populations brief
Accessed November 2017
PQDx 0006-005-00 WHO
PQDx PR
February/2016, version 2.0
Meeting Report
Bangkok, Thailand 8-11 August 2016
PQDx 0144-043-00 WHO
PQDx Public Report
November/2016, version 4.0
HIV & AIDS Treatment in Practice No. 198
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middl
...
Supplement Article
www.jaids.com J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
